Determination of the real-life validity of the Lolli-Method for the detection of RSV, Influenza and SARS-CoV-2 (COVID-19) in the pediatric emergency department

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034956

Enrollment

1000

Registered

2025-01-16

Start date

2025-02-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B97.4 U07.1 J10

Interventions

Group 1: Currently, children in the pediatric emergency department are routinely sampled using a nasal/throat swab and tested for RSV, Influenza and SARS-CoV-2 using a point-of-care PCR-test. With the

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Patient at the Clinic and Polyclinic for Pediatrics and Adolescent Medicine at the University Hospital of Cologne - Testing carried out for RSV, influenza and SARS-CoV-2 as part of the routine care of the Clinic and Polyclinic for Pediatrics and Adolescent Medicine at the University Hospital of Cologne

Exclusion criteria

Exclusion criteria: - Not a patient of the Clinic and Polyclinic for Pediatrics and Adolescent Medicine at the University Hospital of Cologne - No testing for RSV, influenza and SARS-CoV-2 carried out as part of the routine care of the Clinic and Polyclinic for Pediatrics and Adolescent Medicine at the University Hospital of Cologne

Design outcomes

Primary

Measure	Time frame
Test result of the Lolli-swab from children with positive nasal/pharyngeal swab (sensitivity)	—

Secondary

Measure	Time frame
Test result of the Lolli-swab from children with negative nasal/pharyngeal swab (specificity)	—

Countries

Germany

Contacts

Public ContactFelix Dewald

Institut für Virologie

felix.dewald@uk-koeln.de0221 4780

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026